Farzin Haque
Stock Analyst at Jefferies
(3.00)
# 1,279
Out of 5,182 analysts
5
Total ratings
80%
Success rate
63.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Initiates: Buy | $50 | $16.85 | +196.74% | 1 | Mar 30, 2026 | |
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $6.75 | +33.33% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $4.51 | +121.73% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $1.46 | +584.93% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $40.00 | -35.00% | 1 | Nov 10, 2023 |
Vor Biopharma
Mar 30, 2026
Initiates: Buy
Price Target: $50
Current: $16.85
Upside: +196.74%
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $6.75
Upside: +33.33%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.51
Upside: +121.73%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $40.00
Upside: -35.00%